Cargando…

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target

Sarcomas harboring EWSR1-NFATc2 fusions have historically been categorized and treated as Ewing sarcoma. Emerging evidence suggests unique molecular characteristics and chemotherapy sensitivities in EWSR1-NFATc2 fusion positive sarcomas. Comprehensive genomic profiles of 1024 EWSR1 fusion positive s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seligson, Nathan D., Maradiaga, Richard D., Stets, Colin M., Katzenstein, Howard M., Millis, Sherri Z., Rogers, Alan, Hays, John L., Chen, James L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140100/ https://www.ncbi.nlm.nih.gov/pubmed/34021224 http://dx.doi.org/10.1038/s41698-021-00177-0

Ejemplares similares

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma
por: Gouda, Mohamed A., et al.
Publicado: (2023)

Gene partners of the EWSR1 fusion may represent molecularly distinct entities
por: Walker, Victoria, et al.
Publicado: (2023)

EWSR1-NFATC2 and FUS-NFATC2 Gene Fusion-Associated Mesenchymal Tumors: Clinicopathologic Correlation and Literature Review
por: Bode-Lesniewska, Beata, et al.
Publicado: (2019)

High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma
por: Orth, Martin F., et al.
Publicado: (2020)

RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling
por: Wang, Jirong, et al.
Publicado: (2023)

Correction: RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling
por: Wang, Jirong, et al.
Publicado: (2023)

Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging EWSR1/FUS::NFATC2 Neoplasms of the Bone and Soft Tissue
por: Brcic, Iva, et al.
Publicado: (2022)

Rationale for Early Detection of EWSR1 Translocation-Associated Sarcoma Biomarkers in Liquid Biopsy
por: Clanchy, Felix I. L.
Publicado: (2021)

Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma
por: García-Domínguez, Daniel J., et al.
Publicado: (2021)

STIM1 controls calcineurin/Akt/mTOR/NFATC2-mediated osteoclastogenesis induced by RANKL/M-CSF
por: Huang, Yanjiao, et al.
Publicado: (2020)

Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors: A Common Genomic Abnormality in Vascular Malformation/Hemangioma and Simple Bone Cyst
por: Ong, Sheena L.M., et al.
Publicado: (2021)

Targeting mTOR in HIV-Negative Classic Kaposi's Sarcoma
por: Merimsky, Ofer, et al.
Publicado: (2008)

Ewing Sarcoma Protein Ewsr1 Maintains Mitotic Integrity and Proneural Cell Survival in the Zebrafish Embryo
por: Azuma, Mizuki, et al.
Publicado: (2007)

Knockdown of EWSR1/FLI1 expression alters the transcriptome of Ewing sarcoma cells in vitro
por: Wang, Jihan, et al.
Publicado: (2016)

Therapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma
por: Cervera, Saint T., et al.
Publicado: (2021)

Chromosomal localization of Ewing sarcoma EWSR1/FLI1 protein promotes the induction of aneuploidy
por: Park, Hyewon, et al.
Publicado: (2020)

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma
por: Seligson, Nathan D., et al.
Publicado: (2019)

Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets
por: Baldauf, Michaela C., et al.
Publicado: (2017)

Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges
por: Hsu, Jocelyn Y., et al.
Publicado: (2022)

Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma
por: Seligson, Nathan D., et al.
Publicado: (2019)

Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c‐Fos/NFATc1 signaling pathway
por: Jiang, Wenli, et al.
Publicado: (2020)

EWSR1 Rearrangement and CD99 Expression as Diagnostic Biomarkers for Ewing/PNET Sarcomas in a Moroccan Population
por: Louati, Sara, et al.
Publicado: (2018)

An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis
por: García-Domínguez, Daniel J., et al.
Publicado: (2020)

Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a case report and review of the literature
por: Chen, Zhenwei, et al.
Publicado: (2020)

Case report: Ewing sarcoma with EWSR–ERG fusion elevates procalcitonin extremely in the long term without infection
por: Chen, Ying, et al.
Publicado: (2023)

Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene EWSR1::ATF1 by HDAC Inhibition
por: Mae, Hirokazu, et al.
Publicado: (2023)

Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas
por: Seligson, Nathan D., et al.
Publicado: (2022)

Identifying persistent structures in multiscale ‘omics data
por: Zheng, Fan, et al.
Publicado: (2020)

Splice variants denote differences between a cancer stem cell side population of EWSR1-ERG-based Ewing sarcoma cells, its main population and EWSR1-FLI-based cells
por: Korsching, Eberhard, et al.
Publicado: (2022)

Complex/cryptic EWSR1::FLI1/ERG Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas
por: Zou, Ying S., et al.
Publicado: (2023)

Reversion of Hormone Treatment Resistance with the Addition of an mTOR Inhibitor in Endometrial Stromal Sarcoma
por: Martin-Liberal, J., et al.
Publicado: (2014)

Gemcitabine and Selected mTOR Inhibitors in Uterine Sarcomas and Carcinosarcoma Cells- an Isobolographic Analysis
por: Bobiński, Marcin, et al.
Publicado: (2020)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma
por: Li, Bingbing X., et al.
Publicado: (2022)

Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens
por: Hay, Margaret A., et al.
Publicado: (2020)

Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells
por: Franzetti, G-A, et al.
Publicado: (2017)

RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
por: Sánchez-Molina, Sara, et al.
Publicado: (2020)

EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell Sarcoma
por: Möller, Emely, et al.
Publicado: (2022)

Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma
por: Rock, Adam, et al.
Publicado: (2023)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1km5itfadmbtlkk7l04evnbe08